Inflammatory cell signaling pathway (None)

Inflammatory cell signaling pathways refer collectively to the complex network of intracellular cascades that regulate immune responses during inflammation. These include innate immune sensors like Toll-like receptors that detect pathogens or tissue damage and activate downstream effectors such as MAP kinases, NF‑κB, IRFs, and inflammasomes. The result is production of pro-inflammatory cytokines—such as IL‑1β, IL‑6, TNFα—and chemokines that orchestrate leukocyte recruitment and activation. Dysregulation can lead to chronic inflammation implicated in autoimmune diseases, cancer progression, sepsis complications, or persistent infections. While many therapeutics aim at modulating specific nodes within these networks—such as blocking cytokines or their receptors—the term itself does not denote a single druggable entity but rather an interconnected system essential for both protective immunity and pathological conditions when unbalanced.

Other names

Inflammatory signalingImmune cell signaling pathwaysInflammation-related signal transduction

Drugs act by inhibiting or modulating key nodes in inflammatory signal transduction: - Blocking cytokine-receptor interactions. - Inhibiting kinase activity in downstream cascades. - Preventing transcription factor activation and nuclear translocation.